| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3192488 | Annals of Allergy, Asthma & Immunology | 2010 | 7 Pages |
Abstract
Among ED patients with acute asthma, those undergoing salmeterol monotherapy had an increased risk of hospitalization; however, this risk was not seen among patients undergoing combination ICS-salmeterol therapy. Our findings provide data from a unique ED population on clinical response to acute asthma treatment among patients undergoing long-term LABA therapy.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Michael M. MD, Adit A. MD, MPH, Sunday MPH, ScD, Carlos A. MD, DrPH,